Best Places to Work in Industry, 2007

var FO = { movie:"/supplementary/html/52903/Charts/FC_2_3_Column2D.swf", width:"620", height:"420", majorversion:"8", build:"0", xi:"true", flashvars:"&dataURL=/supplementary/html/53144/timeCurrEmployer.xml&chartWidth=620" }; UFO.create(FO, "currEmployer");var FO = { movie:"/supplementary/html/52903/Charts/FC_2_3_Bar2D.swf", width:"620", height:"420", majorversion:"8", build:"0", xi:"true", flashvars:"&dataURL=/supplementary/html/53144/companyAreaWork.xml&chartWidth=620&chartH

Written byEdyta Zielinska
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Failure parties, foosball tables, and scientific sabbaticals are just some of the things that make this year's top companies stand out from the crowd.
By Edyta Zielinska

ARTICLE EXTRAS

When a project gets cut, Inspire Pharmaceuticals acknowledges the amount of work a team had invested into a project in a rather unusual way. "We have failure parties," says Ward Peterson, vice president of discovery. The company, which develops treatments for ophthalmic and respiratory/allergy diseases, placed fourth in this year's survey by The Scientist of Best Places to Work in Industry. Before taking the team out for a dinner to celebrate their efforts, employees at Inspire write out their favorite things about the project and plaster a wall with their comments.

In our fifth annual survey, scientists ranked appreciation for their efforts as the second most important factor that defines a good workplace, right behind personal satisfaction. "Trying to find new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies